Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?
作者:
主题词
老年人(Aged);阿尔茨海默病(Alzheimer Disease);淀粉样β肽类(Amyloid beta-Peptides);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);载脂蛋白E类(Apolipoproteins E);阿司匹林(Aspirin);脑源性神经营养因子(Brain-Derived Neurotrophic Factor);二十二碳六烯酸类(Docosahexaenoic Acids);女(雌)性(Female);海马(Hippocampus);人类(Humans);新皮质(Neocortex);神经通路(Neural Pathways);过氧化物酶体增殖物激活受体(Peroxisome Proliferator-Activated Receptors);危险因素(Risk Factors);妇女(Women)
DOI
10.1016/j.arr.2010.09.003
PMID
20920611
发布时间
2013-11-21
- 浏览7

Ageing research reviews
124-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文